Effector molecules such as CD25, IFN-γ, and TNF-α were then elevated in these treated cells, demonstrating enhanced cytotoxic activity and potential for pentanoate and C4 as supplements to cancer treatment for some malignancies (Figure 2D). This evidence concerns the gene TNF and cancer.